120 related articles for article (PubMed ID: 29935911)
1. Cervical cancer care in rural Virginia: The impact of distance from an academic medical center on outcomes & the role of non-specialized radiation centers.
Rauh LA; Saks EJ; Nakad-Rodriguez D; Showalter TN; Duska LR
Gynecol Oncol; 2018 Aug; 150(2):338-342. PubMed ID: 29935911
[TBL] [Abstract][Full Text] [Related]
2. Distance from a Comprehensive Cancer Center: A proxy for poor cervical cancer outcomes?
Barrington DA; Dilley SE; Landers EE; Thomas ED; Boone JD; Straughn JM; McGwin G; Leath CA
Gynecol Oncol; 2016 Dec; 143(3):617-621. PubMed ID: 27720232
[TBL] [Abstract][Full Text] [Related]
3. Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer.
Vetterlein MW; Löppenberg B; Karabon P; Dalela D; Jindal T; Sood A; Chun FK; Trinh QD; Menon M; Abdollah F
Cancer; 2017 Sep; 123(17):3241-3252. PubMed ID: 28472547
[TBL] [Abstract][Full Text] [Related]
4. Examining Urban and Rural Differences in How Distance to Care Influences the Initiation and Completion of Treatment among Insured Cervical Cancer Patients.
Spees LP; Brewster WR; Varia MA; Weinberger M; Baggett C; Zhou X; Petermann VM; Wheeler SB
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):882-889. PubMed ID: 30733307
[TBL] [Abstract][Full Text] [Related]
5. Distance traveled for treatment of cervical cancer: who travels the farthest, and does it impact outcome?
Gunderson CC; Nugent EK; McMeekin DS; Moore KN
Int J Gynecol Cancer; 2013 Jul; 23(6):1099-103. PubMed ID: 23765207
[TBL] [Abstract][Full Text] [Related]
6. National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements.
Gill BS; Lin JF; Krivak TC; Sukumvanich P; Laskey RA; Ross MS; Lesnock JL; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1083-90. PubMed ID: 25216857
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2-IVA cervical cancer and its clinical prognostic factors.
Fujiwara M; Isohashi F; Mabuchi S; Yoshioka Y; Seo Y; Suzuki O; Sumida I; Hayashi K; Kimura T; Ogawa K
J Radiat Res; 2015 Mar; 56(2):305-14. PubMed ID: 25428244
[TBL] [Abstract][Full Text] [Related]
8. Disparities in the management and outcome of cervical cancer in the United States according to health insurance status.
Churilla T; Egleston B; Dong Y; Shaikh T; Murphy C; Mantia-Smaldone G; Chu C; Rubin S; Anderson P
Gynecol Oncol; 2016 Jun; 141(3):516-523. PubMed ID: 27012428
[TBL] [Abstract][Full Text] [Related]
9. Clinical Role of Adjuvant Chemotherapy after Radical Hysterectomy for FIGO Stage IB-IIA Cervical Cancer: Comparison with Adjuvant RT/CCRT Using Inverse-Probability-of-Treatment Weighting.
Jung PS; Kim DY; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
PLoS One; 2015; 10(7):e0132298. PubMed ID: 26176626
[TBL] [Abstract][Full Text] [Related]
10. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer survival for patients referred to a tertiary care center in Kentucky.
Seamon LG; Tarrant RL; Fleming ST; Vanderpool RC; Pachtman S; Podzielinski I; Branscum AJ; Feddock JM; Randall ME; Desimone CP
Gynecol Oncol; 2011 Dec; 123(3):565-70. PubMed ID: 21963092
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of chemoradiotherapy in cervical cancer--the Western Australian experience.
Lim A; Sia S
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1431-8. PubMed ID: 21640504
[TBL] [Abstract][Full Text] [Related]
13. Impact of facility volume on therapy and survival for locally advanced cervical cancer.
Lin JF; Berger JL; Krivak TC; Beriwal S; Chan JK; Sukumvanich P; Monk BJ; Richard SD
Gynecol Oncol; 2014 Feb; 132(2):416-22. PubMed ID: 24333361
[TBL] [Abstract][Full Text] [Related]
14. Class II versus Class III radical hysterectomy in early cervical cancer: an observational study in a tertiary center.
Ditto A; Martinelli F; Ramondino S; Vullo SL; Carcangiu M; Haeusler E; Mariani L; Lorusso D; Raspagliesi F
Eur J Surg Oncol; 2014 Jul; 40(7):883-90. PubMed ID: 24613739
[TBL] [Abstract][Full Text] [Related]
15. The significance of tumoral ERCC1 status in patients with locally advanced cervical cancer treated with chemoradiation therapy: a multicenter clinicopathologic analysis.
Doll CM; Aquino-Parsons C; Pintilie M; Klimowicz AC; Petrillo SK; Milosevic M; Craighead PS; Clarke B; Lees-Miller SP; Fyles AW; Magliocco AM
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):721-7. PubMed ID: 22836058
[TBL] [Abstract][Full Text] [Related]
16. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.
Mabuchi S; Isohashi F; Okazawa M; Kitada F; Maruoka S; Ogawa K; Kimura T
J Gynecol Oncol; 2017 Jan; 28(1):e15. PubMed ID: 27958682
[TBL] [Abstract][Full Text] [Related]
17. Determinants of Quality Care and Mortality for Patients With Locally Advanced Cervical Cancer in Virginia.
Showalter TN; Camacho F; Cantrell LA; Anderson RT
Medicine (Baltimore); 2016 Feb; 95(8):e2913. PubMed ID: 26937934
[TBL] [Abstract][Full Text] [Related]
18. Combined chemoradiation of cisplatin versus carboplatin in cervical carcinoma: a single institution experience from Thailand.
Tharavichitkul E; Lorvidhaya V; Kamnerdsupaphon P; Sukthomya V; Chakrabandhu S; Klunklin P; Onchan W; Supawongwattana B; Pukanhaphan N; Galalae R; Chitapanarux I
BMC Cancer; 2016 Jul; 16():501. PubMed ID: 27435245
[TBL] [Abstract][Full Text] [Related]
19. Impact of Travel Distance and Urban-Rural Status on the Multidisciplinary Management of Rectal Cancer.
Loree JM; Javaheri KR; Lefresne SV; Speers CH; Ruan JY; Chang JT; Brown CJ; Kennecke HF; Olson RA; Cheung WY
J Rural Health; 2017 Sep; 33(4):393-401. PubMed ID: 27717002
[TBL] [Abstract][Full Text] [Related]
20. Lymphopenia and its association with survival in patients with locally advanced cervical cancer.
Wu ES; Oduyebo T; Cobb LP; Cholakian D; Kong X; Fader AN; Levinson KL; Tanner EJ; Stone RL; Piotrowski A; Grossman S; Roche KL
Gynecol Oncol; 2016 Jan; 140(1):76-82. PubMed ID: 26571200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]